Literature DB >> 18684738

PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.

Tiago L Moda1, Leonardo G Torres, Alexandre E Carrara, Adriano D Andricopulo.   

Abstract

UNLABELLED: The study of pharmacokinetic properties (PK) is of great importance in drug discovery and development. In the present work, PK/DB (a new freely available database for PK) was designed with the aim of creating robust databases for pharmacokinetic studies and in silico absorption, distribution, metabolism and excretion (ADME) prediction. Comprehensive, web-based and easy to access, PK/DB manages 1203 compounds which represent 2973 pharmacokinetic measurements, including five models for in silico ADME prediction (human intestinal absorption, human oral bioavailability, plasma protein binding, blood-brain barrier and water solubility). AVAILABILITY: http://www.pkdb.ifsc.usp.br

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684738     DOI: 10.1093/bioinformatics/btn415

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  14 in total

Review 1.  Fragment-based QSAR: perspectives in drug design.

Authors:  Lívia B Salum; Adriano D Andricopulo
Journal:  Mol Divers       Date:  2009-01-31       Impact factor: 2.943

Review 2.  Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms.

Authors:  Carlie A LaLone; Jason P Berninger; Daniel L Villeneuve; Gerald T Ankley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-11-19       Impact factor: 6.237

3.  Data Sets Representative of the Structures and Experimental Properties of FDA-Approved Drugs.

Authors:  Dominique Douguet
Journal:  ACS Med Chem Lett       Date:  2018-01-29       Impact factor: 4.345

4.  PK-DB: pharmacokinetics database for individualized and stratified computational modeling.

Authors:  Jan Grzegorzewski; Janosch Brandhorst; Kathleen Green; Dimitra Eleftheriadou; Yannick Duport; Florian Barthorscht; Adrian Köller; Danny Yu Jia Ke; Sara De Angelis; Matthias König
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

5.  The use of pseudo-equilibrium constant affords improved QSAR models of human plasma protein binding.

Authors:  Xiang-Wei Zhu; Alexander Sedykh; Hao Zhu; Shu-Shen Liu; Alexander Tropsha
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

6.  Evaluation of Quantitative Structure Property Relationship Algorithms for Predicting Plasma Protein Binding in Humans.

Authors:  Yejin Esther Yun; Rogelio Tornero-Velez; S Thomas Purucker; Daniel T Chang; Andrea N Edginton
Journal:  Comput Toxicol       Date:  2021-02-01

7.  Identification and characterization of novel small-molecule inhibitors against hepatitis delta virus replication by using docking strategies.

Authors:  Sarita Singh; Sunil Kumar Gupta; Anuradha Nischal; Sanjay Khattri; Rajendra Nath; Kamlesh Kumar Pant; Prahlad Kishore Seth
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

8.  DrugBank 4.0: shedding new light on drug metabolism.

Authors:  Vivian Law; Craig Knox; Yannick Djoumbou; Tim Jewison; An Chi Guo; Yifeng Liu; Adam Maciejewski; David Arndt; Michael Wilson; Vanessa Neveu; Alexandra Tang; Geraldine Gabriel; Carol Ly; Sakina Adamjee; Zerihun T Dame; Beomsoo Han; You Zhou; David S Wishart
Journal:  Nucleic Acids Res       Date:  2013-11-06       Impact factor: 16.971

9.  pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.

Authors:  Douglas E V Pires; Tom L Blundell; David B Ascher
Journal:  J Med Chem       Date:  2015-04-22       Impact factor: 7.446

10.  IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data.

Authors:  Ashenafi Legehar; Henri Xhaard; Leo Ghemtio
Journal:  J Cheminform       Date:  2016-06-14       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.